A house fire on Ferry Point Road in Virginia Beach injured one woman and displaced three people. One dog died after rescue; two others were found dead.
Vietnam is entering a decisive phase of its development. As global supply chains reorganise, foreign investors reassess risk, ...
Cuba has turned to Africa for fuel supplies after the loss of regular oil shipments from Venezuela and dwindling deliveries ...
For decades, airlines have obsessively shaved every possible gram from their cabins — swapping heavy silverware for plastic, ...
Madurai: Doctors at Government Rajaji Hospital in Madurai declared a first-year college student dead after she consumed a substance known as borax (locally called Vengaram) for weight ...
Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...
Novo Nordisk’s wildly successful obesity medicine is now available as a pill, making it the first GLP-1 pill for weight loss in the United States. The pill is available in four doses and is cheaper ...
A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...
If you’re ready to change your life but don’t know where to begin, Running for Weight Loss offers a clear, supportive path forward. Guided by experts, you’ll learn how metabolism works, understand ...
Running is a popular form of exercise for people looking to lose weight. And there’s good reason for that: It’s a really efficient way to expend energy, which is helpful when you’re striving to burn ...
GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...